Page 56 - Read Online
P. 56
Pintos-Morell et al. Rare Dis Orphan Drugs J 2024;3:12 https://dx.doi.org/10.20517/rdodj.2023.52 Page 15 of 15
bioinformatics tools and rapid second-tier DNA analyses. Int J Neonatal Screen 2020;6:51. DOI PubMed PMC
31. Spiekerkoetter U, Bick D, Scott R, et al. Genomic newborn screening: are we entering a new era of screening? J Inherit Metab Dis
2023;46:778-95. DOI
32. Bros-Facer V, Taylor S, Patch C. Next-generation sequencing-based newborn screening initiatives in Europe: an overview. Rare Dis
Orphan Drugs J 2023;2:21. DOI
33. Goldenberg AJ, Ponsaran R, Gaviglio A, Simancek D, Tarini BA. Genomics and newborn screening: perspectives of public health
programs. Int J Neonatal Screen 2022;8:11. DOI PubMed PMC
34. White S, Mossfield T, Fleming J, et al. Expanding the Australian newborn blood spot screening program using genomic sequencing:
do we want it and are we ready? Eur J Hum Genet 2023;31:703-11. DOI PubMed PMC
35. Smedley D, Smith KR, Martin A, et al. 100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report. N Engl J
Med 2021;385:1868-80. DOI PubMed PMC
36. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual
disability: 2021 review and digital app. Orphanet J Rare Dis 2021;16:170. DOI PubMed PMC
37. Gold NB, Adelson SM, Shah N, et al. Perspectives of rare disease experts on newborn genome sequencing. JAMA Netw Open
2023;6:e2312231. DOI PubMed PMC
38. Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies
inborn disorders of neonates. Orphanet J Rare Dis 2022;17:66. DOI PubMed PMC
39. Magnifico G, Artuso I, Benvenuti S. A systematic review of real-world applications of genome sequencing for newborn screening.
Rare Dis Orphan Drugs J 2023;2:16. DOI
40. Balciuniene J, Liu R, Bean L, et al. At-risk genomic findings for pediatric-onset disorders from genome sequencing vs medically
actionable gene panel in proactive screening of newborns and children. JAMA Netw Open 2023;6:e2326445. DOI PubMed PMC
41. Bailey DB Jr, Porter KA, Andrews SM, Raspa M, Gwaltney AY, Peay HL. Expert evaluation of strategies to modernize Newborn
Screening in the United States. JAMA Netw Open 2021;4:e2140998. DOI PubMed PMC
42. Millington DS, Bali DS. Current state of the art of newborn screening for lysosomal storage disorders. Int J Neonatal Screen
2018;4:24. DOI PubMed PMC
43. Kubaski F, Sousa I, Amorim T, et al. Pilot study of newborn screening for six lysosomal diseases in Brazil. Mol Genet Metab
2023;140:107654. DOI
44. Tangeraas T, Constante JR, Backe PH, et al. BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn
screening. Brain 2023;146:3003-13. DOI
45. Plecko B. On pathways and blind alleys-the importance of biomarkers in vitamin B -dependent epilepsies. J Inherit Metab Dis
6
2023;46:839-47. DOI PubMed
46. Abiusi E, Vaisfeld A, Fiori S, et al. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific
guidelines and standard operating procedures for the molecular diagnosis. J Med Genet 2023;60:697-705. DOI
47. Genomics England. Conditions list. List of the genes and conditions that will be included when the Generation Study begins. Available
from: https://www.genomicsengland.co.uk/initiatives/newborns/choosing-conditions/conditions-list-generation-study [Last accessed
on 23 Apr 2024].
48. Liang NSY, Watts-Dickens A, Chitayat D, Babul-Hirji R, Chakraborty P, Hayeems RZ. Parental preferences for expanded newborn
screening: what are the limits? Children 2023;10:1362. DOI PubMed PMC
49. Rehm HL, Alaimo JT, Aradhya S, et al; Medical Genome Initiative Steering Committee. The landscape of reported VUS in multi-gene
panel and genomic testing: time for a change. Genet Med 2023;25:100947. DOI PubMed PMC
50. Wu X, Yang Y, Zhou L, Long W, Yu B. Are we ready for newborn genetic screening? A cross-sectional survey of healthcare
professionals in southeast China Front Pediatr 2022;10:875229. DOI PubMed PMC